Podcasts about healthcare innovation

In 1987, Mary P. Lovato, a member of Kewa Pueblo in New Mexico, was diagnosed with acute leukemia. To receive a bone marrow transplant, she had to travel more than 800 miles from home because specialized cancer care was unavailable through the Indian Health Service. When she returned, she discovered another obstacle: many in her community feared cancer so deeply that they avoided speaking about it altogether.This episode examines how cancer survivorship exposed profound inequities in the American healthcare system. Long before health equity became a national priority, advocates from underserved communities were confronting disparities rooted in geography, poverty, racism, language, underfunded healthcare systems, and historical mistrust of medical institutions. Their work demonstrated that scientific advances alone cannot improve survival if patients cannot reach, afford, or trust the care available to them.The story follows pioneers including Mary P. Lovato, who built the first national Native-led cancer support and education program for Indigenous communities, and Maimah Karmo, founder of the Tigerlily Foundation, whose breast cancer diagnosis inspired a movement to improve early detection, clinical trial participation, and representation for Black women. Their advocacy challenged longstanding barriers to culturally competent care while highlighting persistent inequities in access to screening, fertility preservation, navigation, and innovative treatments.The episode also explores why diversity in clinical research matters. For decades, many cancer clinical trials disproportionately enrolled White patients, limiting both access to promising therapies and the scientific understanding of how treatments perform across different populations. Researchers, patient advocates, and community leaders responded by redesigning outreach, improving patient navigation, reducing logistical barriers, and insisting that affected communities help shape the research itself.Cancer survivorship cannot be measured solely by scientific breakthroughs. It also depends on whether every patient has a meaningful opportunity to benefit from them. The pursuit of health equity remains one of the defining challenges and enduring responsibilities of modern oncology.RELATED LINKSNational Cancer Institute | Cancer Health Disparities⁠Indian Health Service⁠Tigerlily Foundation⁠National Cancer Institute | Cancer Clinical Trials⁠American Indian Cancer Foundation⁠Abramson Cancer Center | University of Pennsylvania⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Most people think occupational therapy is what happens after something goes wrong. Tyler Broome is here to tell you that's exactly the framing that's costing patients their independence. In this episode of the Your Health University Podcast, Jamie sits down with Tyler Broome, a Certified Occupational Therapist Assistant at Your Health, to explore what OT actually is, how it fits into a truly integrated care model, and why the therapy team often sees the earliest signs of decline — before anyone else on the care team does. Tyler brings a uniquely grounded perspective, shaped by a baseball career, a grandmother's fall, and years of working inside the homes of real patients. He articulates something most healthcare systems have yet to fully grasp: that medical outcomes and functional outcomes are deeply connected, and that a care team working in silos is a care team leaving gaps. In this episode: Why occupational therapy is defined by daily function — bathing, dressing, meal prep, medication management — not just physical recovery How OT's presence in the home gives the care team "functional health intelligence" no clinic visit can replicate The difference between saying your system is integrated and actually delivering integrated care Two real patient stories where early cross-disciplinary communication prevented a crisis from becoming a catastrophe Why the shift to value-based care makes therapy's role not just important — but essential If you work inside the Your Health system — or if you've ever wondered what the therapy team actually contributes — this conversation will change how you think about the care happening around your patients every day. www.YourHealth.Org

In 2000, Katie Couric underwent a live colonoscopy on national television following the death of her husband, Jay Monahan, from colorectal cancer at age 42. The broadcast demystified a procedure many Americans feared, led to an estimated 20% increase in colonoscopy screenings, and became one of the clearest examples of how public storytelling can change healthcare behavior.This episode examines how celebrities, journalists, filmmakers, and entertainers helped reshape the public conversation about cancer during a period when survivorship was becoming increasingly visible. As breakthroughs in targeted therapies, immunotherapy, and early detection allowed more people to live beyond cancer, public figures used their platforms to encourage screening, reduce stigma, and accelerate research. Their influence extended far beyond awareness campaigns, helping transform cancer from a private diagnosis into a national public health conversation.Central to this story is Laura Ziskin, the Hollywood producer behind Pretty Woman and the Spider-Man films, whose metastatic breast cancer diagnosis inspired the creation of Stand Up To Cancer. Working alongside Couric and leaders from entertainment, journalism, and biomedical research, Ziskin championed a new funding model that required multidisciplinary scientific collaboration, helping accelerate discoveries that contributed to multiple FDA-approved cancer therapies. The episode also highlights the advocacy of actor Patrick Dempsey, whose family's experience with ovarian cancer led to the creation of the Dempsey Center, expanding support for patients and caregivers beyond medical treatment.The story also asks what celebrity advocacy often leaves unsaid. Financial toxicity, caregiver burden, chronic pain, mental health, and the long-term effects of treatment rarely receive the same attention as dramatic diagnoses or breakthrough cures. As cancer survivorship continues to evolve, the greatest challenge may not be convincing people to care about cancer, but helping them understand what it truly means to live with and beyond it.RELATED LINKSStand Up To Cancer⁠Katie Couric Media⁠Dempsey Center⁠American Association for Cancer Research⁠National Cancer Institute⁠Dana-Farber Cancer Institute | Adult Survivorship Program⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Finding heart failure earlier gives patients a better chance to begin treatment before the disease progresses. In this episode, Roger Owens, Chief Commercial Officer at Ultromics, discusses how AI-powered echocardiography can improve the early detection of HFpEF and cardiac amyloidosis. He explains how EchoGo integrates seamlessly into existing hospital workflows, enabling physicians to identify signs of heart failure from standard echocardiograms. Roger also explores the operational, reimbursement, and implementation challenges healthcare organizations face when adopting AI in clinical practice. He emphasizes that advances in treatment options make earlier diagnosis increasingly important for improving patient outcomes. Tune in to discover how AI-powered cardiac diagnostics can support earlier intervention and better patient outcomes! Resources: Connect with and follow Roger Owens on LinkedIn. Follow Ultromics on LinkedIn and explore their website!

In 2006, a landmark report titled Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer confirmed what young survivors had been saying for years. While survival rates for children and older adults had steadily improved, adolescents and young adults had experienced decades of stalled progress. They had become cancer's lost generation.This episode explores how young adult survivors transformed their shared isolation into one of the most influential grassroots movements in cancer advocacy. Diagnosed during the years typically devoted to education, careers, relationships, and starting families, patients between the ages of 15 and 39 confronted challenges that extended far beyond treatment. Fertility preservation, sexual health, employment, financial toxicity, insurance, and long-term quality of life were rarely discussed in oncology clinics, leaving many to navigate survivorship alone.The episode follows advocates including Tamika Felder, Lindsay Avner, Heidi Adams, Doug Ulman, and Dr. Archie Bleyer, whose research and advocacy fundamentally changed how medicine understands adolescent and young adult cancer. Through organizations including Planet Cancer, Fertile Hope, the Lance Armstrong Foundation, and later Stupid Cancer, survivors built online communities, educational resources, conferences, and national partnerships that challenged long-standing assumptions about cancer care. Their work helped establish fertility preservation as a standard discussion before treatment, expanded research dedicated to adolescent and young adult oncology, and elevated quality of life as a critical clinical outcome alongside survival.The movement also demonstrated the power of lived experience to reshape medicine. Survivors became researchers, educators, nonprofit founders, and policy advocates, insisting that cancer care account not only for years of life saved, but for the lives patients hoped to build afterward.What began as a search for peers evolved into a national movement that permanently transformed adolescent and young adult oncology. Today, dedicated research programs, clinical fellowships, survivorship resources, and patient advocacy organizations continue to build on the foundation these young cancer mavericks created.RELATED LINKSNational Cancer Institute | Adolescent and Young Adult (AYA) Cancer Program⁠Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer⁠American Society of Clinical Oncology | Fertility Preservation Guidelines⁠Stupid Cancer⁠Livestrong Foundation⁠Journal of Adolescent and Young Adult Oncology⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if healthcare wasn't just about treating disease—but helping people become the strongest, healthiest, most vibrant version of themselves?In this fascinating and forward-thinking episode, I sit down with John Goldman, Human Performance Advocate, visionary in Precision Medicine, and Founder & CEO of Rebel Health Alliance.John shares why he rebelled against the traditional healthcare system and created a revolutionary parallel healthcare model focused on prevention, optimization, and coordinated personalized care. Instead of waiting until people get sick, Rebel Health Alliance is designed to help individuals proactively improve their health, energy, resilience, and quality of life through data-driven, highly personalized support.We explore how modern lifestyles are quietly making many people sick and overweight—and why small daily habits, consistency, structure, and proactive health choices can dramatically transform our future.John explains how Rebel Health Alliance combines cutting-edge diagnostic technology with a carefully curated team of experts—including doctors, strength coaches, dieticians, and epigenetic counselors—all coordinated around the individual. Through virtual care, members gain convenient access to personalized support through text, voice, and video while keeping costs more affordable than traditional healthcare models.One of the most inspiring moments in the conversation is when John shares his personal goal of becoming a “bad ass grandpa”—living a long, healthy, energetic life filled with vitality and purpose. His mission is not simply helping people avoid illness, but helping them truly thrive.We also discuss:Why prevention matters more than waiting for diseaseThe limitations of insurance-based healthcareThe importance of discipline and daily habitsRebuilding energy, focus, and resiliencePrecision medicine and personalized careThe role of accountability and support in long-term transformationCost-sharing options for unexpected medical emergenciesWhy health optimization should feel personal and human—not transactionalJohn's passion for empowering people to take ownership of their health is contagious, and this episode offers hope for anyone searching for a more proactive and personalized approach to wellness.You can learn more about John and Rebel Health Alliance at: Rebel Health Alliance WebsiteConnect with John on social media:Twitter/X @JohnGoldmanInstagramLinkedInIf you enjoyed this episode, please share it with someone who is ready to take a proactive approach to their health and future.Listen, Share, and SupportIf this episode resonated with you, please share it with someone who may need hope today.Be sure to subscribe, leave a rating and review, and help us spread more healing and inspiration to the world.Free Resource for HealingIf you're ready to release stress, calm your mind, and begin healing from within, visit:

There's a number attached to every patient's chart that quietly shapes the resources they receive, the care they're offered, and whether their health conditions are fully seen — and most providers don't fully understand it. In this episode, Jamie sits down with Ericka Bauman, Director of Quality Assurance at Your Health, to break down the Risk Adjustment Factor — better known as the RAF score. Ericka has spent years traveling across Georgia and South Carolina, walking into provider offices, sitting with care teams, and doing the work of turning confusing data into meaningful patient outcomes. What you'll hear in this episode: What the RAF score actually is — explained the way Erica explains it to every team she visits, from providers to front desk staff Why most RAF scores are too low — and how underdocumenting a patient's conditions leaves them exposed to missed care, hospitalizations, and unmet needs The biggest misconception providers have about RAF (hint: it's not another box to check) How RAF and quality measurement are really asking the same question from two different angles — and why treating them separately is a mistake What changes for patients when care teams show up prepared, proactive, and looking at the whole person — not just the reason for today's visit The numbers will follow when you take care of the patient. This episode will show you how. www.YourHealth.Org

In 2006, the Institute of Medicine published From Cancer Patient to Cancer Survivor: Lost in Transition, concluding that millions of Americans were surviving cancer only to find themselves navigating a healthcare system unprepared for life after treatment. The report challenged oncology to recognize that curing cancer was not the end of care, but the beginning of survivorship.This episode explores how the growing cancer survivorship movement exposed the long-term consequences of cancer treatment that medicine had largely overlooked. As survival rates improved following the National Cancer Act of 1971, millions of survivors faced chronic fatigue, neuropathy, infertility, cognitive impairment, financial hardship, employment discrimination, anxiety, depression, and post-traumatic stress. These were not rare complications. They became defining features of survivorship for many patients.Drawing on the work of oncologist Dr. Patricia Ganz, survivor advocate Ellen Stovall, and researchers, clinicians, and survivors across the country, the episode examines how survivorship research expanded beyond recurrence and mortality to include quality of life, psychosocial care, rehabilitation, and long-term follow-up. Their efforts helped establish survivorship care plans, multidisciplinary survivorship clinics, and a broader understanding that cancer affects every aspect of a person's life long after treatment ends.The episode also confronts persistent inequities in survivorship care. Insurance coverage often ends when treatment stops, supportive services remain inconsistent, financial toxicity continues to drive medical hardship, and racial, geographic, and socioeconomic disparities still influence who receives comprehensive follow-up care. For many survivors, finishing treatment simply marks the beginning of another struggle.Modern oncology increasingly recognizes that surviving cancer is measured by more than years of life. It is also measured by quality of life, dignity, access to care, and the ability to rebuild a future after treatment. That evolution remains one of the most significant legacies of the cancer survivorship movement.RELATED LINKSNational Academy of Medicine | ⁠From Cancer Patient to Cancer Survivor: Lost in Transition⁠National Cancer Institute Office of Cancer Survivorship⁠American Society of Clinical Oncology | Survivorship Compendium⁠CancerCare⁠HopeWell Cancer Support⁠National Coalition for Cancer Survivorship⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Jay Rughani, Partner at @a16z, discusses the rise of “infinite healthcare,” AI's potential to expand access to care, and what separates high-impact healthcare founders from the rest.

In 1967, breast surgeon Dr. Harold P. Freeman arrived at Harlem Hospital expecting to treat cancer. Instead, he confronted a healthcare system where poverty, racism, lack of insurance, and institutional barriers often determined who lived long enough to receive treatment. Patients frequently arrived with advanced disease, not because medicine lacked answers, but because access to care had failed them.This episode explores how cancer survivorship expanded beyond medical breakthroughs to include healthcare access, health equity, and organized advocacy. Building on the early work of the National Coalition for Cancer Survivorship (NCCS), it examines the recognition that surviving cancer depended not only on research, but also on whether patients could navigate a fragmented healthcare system.Freeman responded by creating one of the nation's first patient navigation programs at Harlem Hospital in 1990. Community-based navigators helped patients overcome practical barriers including insurance, transportation, appointments, communication, and fear. The model dramatically improved timely diagnosis and treatment, increased breast cancer survival in Harlem, and ultimately inspired the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005, establishing navigation as a cornerstone of modern oncology care.The episode also follows cancer survivor Ellen Stovall, whose leadership transformed survivorship into a national policy movement. Through the NCCS, she united advocates across cancer types, fought for insurance protections, expanded access to clinical trials, helped shape the creation of the Office of Cancer Survivorship at the National Cancer Institute, and organized the landmark 1998 National March for Cancer Survivorship in Washington, D.C. Her work reframed survivorship as a public policy issue rather than a personal experience.Together, Freeman and Stovall demonstrated that scientific progress alone could not eliminate disparities in cancer outcomes. Their work established two enduring principles that continue to shape oncology today: patients need someone to help them navigate care, and survivors must have a voice in the policies that govern it. Modern cancer survivorship depends on both.RELATED LINKSNational Coalition for Cancer Survivorship⁠Harold P. Freeman Patient Navigation Institute⁠National Cancer Institute Office of Cancer Survivorship⁠Patient Navigator Outreach and Chronic Disease Prevention Act of 2005⁠American Cancer Society⁠Tuskegee Study Timeline | Centers for Disease Control and Prevention⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Most nursing homes think they're measuring success by how many patients move through their building. What they're not measuring is how many of those same patients end up right back in the hospital — and who pays the price when they do. In this episode of The Disrupted Podcast, Scott Middleton — Owner of Your Health and Chief Disruption Officer — pulls back the curtain on the facility partnership model Your Health is rolling out across the Southeast. It's a model that doesn't just serve patients in skilled nursing facilities; it pays those facilities for the care coordination work their staff is already doing, while creating the kind of presence that actually moves the needle on outcomes. Scott and Jamie cover the mechanics, the competitive landscape, and the cultural shift required to make it all work: Why Your Health is contracting with nursing homes to pay up to $20,000 a month for care coordination — and what that's worth annually to a facility with 200 Medicare patients The difference between "popping in" and genuine presence — and why only one of them drives real cost savings and keeps patients from bouncing back to the hospital Why physicians working in isolation are the biggest liability in a team-based care model, and how a September 1st bonus restructure is designed to change that culture How 80% of what used to require an in-person visit can now happen via telehealth — and the one thing technology will never replace: the relationship that makes a patient actually follow through Scott's 10-year urgency: why Your Health is already three steps ahead of the competition — and why that lead only matters if the model scales fast enough If you work in a nursing facility, lead a care team, run a healthcare organization, or believe the system needs a fundamentally better architecture — this is what building it actually looks like. Press play. www.YourHealth.Org

Organizations demand infinite growth in finite markets. Leaders are left at the crossroads of irreconcilable missions, balancing economic imperatives with the well-being of their teams. What happens when the equation simply has no solution? The cost of execution is sometimes your own breaking point.Welcome to Pharma Minds, Summer Series "Executing differently takes courage". For this final episode of our miniseries, I wanted to explore what execution reveals about oneself at the deepest level. I chose to speak with Patrice because his journey shows what it concretely costs to actually do what you said you would do. Execution eventually ceases to be a professional requirement. It becomes a personal decision to put skin in the game, without a safety net, but with singular intention. Patrice Zagame is the Founder and CEO of Eolias Health, an OTC lab for plant-based products aimed at the Brazilian market. After spending 35 years in the pharmaceutical industry and managing global subsidiaries for 16 years, he knows the weight of impossible contexts. From handling severe price cuts and sales force reductions in France to surviving executive burnout and ultimately funding his own venture, Patrice embodies the courage of leaving the comfort of a massive organization to truly walk the talk.In this episode, we cover:◾️The Impossible Equation : Balancing double-digit growth demands with saturated markets and massive price cuts.◾️Choice Versus Chance : Why letting an organization dictate your pace can cost you the most crucial turns in your career.◾️The Silent Break : Recognizing the boiling point of executive burnout and walking away to change the equation.◾️Managing the Smartest Room : Stepping back from ego to lead experts who know more than you do.◾️Walking the Talk : Leaving corporate security to fund an entrepreneurial venture from scratch.Commitment is not a corporate posture. It is a daily decision renewed in the face of impossible contexts. At some point, managing the system is no longer enough. 

Welcome to a very, very, very special bonus episode of Out of Patients, and one unlike anything published on this feed before. For nearly 20 years, Matthew Zachary has handed these microphones to patients, caregivers, doctors, advocates, troublemakers, and people with something worth saying. This time, he handed them to his daughter. Hannah Greenzweig grew up around this show, and now she has commandeered the studio with 3 of her wonderfully creative high school friends to talk about something they built entirely themselves. There is an enormous amount of Dad Pride baked into this episode, along with the strange and wonderful realization that sometimes your kid grows up, takes your chair, takes your microphone, and produces a better show without you.Hannah Greenzweig, Michael Aidinov, Gwendolyn Baldini, and Astronomy are student artists from the Roundabout Youth Ensemble at James Madison High School in Brooklyn. Working alongside teaching artists from Roundabout Theatre Company, they spent a school year creating an original play from the ground up, writing every scene, developing every character, and producing the performance themselves.Instead of discussing a Broadway production, they dissect one they invented.Their play, Subject Matter, began with a room full of improbable ideas. Murderous bounce houses, pirate family sagas, underwater adventures, courtroom dance battles, and birthday parties at math museums all competed before the group settled on an absurd rivalry between New York's fictional History Museum and Math Museum. From there, they built a fully staged comedy about institutional competition, sabotage, oversized personalities, and the unexpected discovery that history and mathematics need each other more than either side wants to admit.The conversation pulls back the curtain on a creative process most audiences never see. The students explain how scenes evolved through constant rewrites, how characters emerged from improvisation, how costumes came together with last minute ingenuity, and how rehearsals often collapsed into uncontrollable laughter. They recount cutting favorite ideas, solving production problems with limited resources, and trusting each other enough to keep rewriting until the story worked.The episode also captures something harder to script: teenagers speaking honestly about collaboration without adults translating their experience. They celebrate classmates who stepped into unexpected roles, teachers who quietly held the production together, and the strange joy of creating something that exists only because everyone showed up.It is a conversation about theater, friendship, education, creativity, and what happens when 4 young artists get the microphones and the adults get out of the way.RELATED LINKSRoundabout Theatre CompanyRoundabout Youth EnsembleJames Madison High SchoolFEEDBACKLike this bonus episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A man is struck by a car on the streets of Los Angeles. In the emergency department, a CT scan ordered to look for traumatic injuries reveals something nobody expected: a mass in his colon. Days later, sitting across from Dr. Belinda Waltman, he calls the accident “a blessing in disguise.” Then he changes the subject. He is less worried about cancer than about whether he can afford to miss another day of work. In this season finale of Standard Deviation, host Dr. Oliver Bogler explores what happens when biomedical science collides with the realities of the healthcare safety net. Dr. Waltman, a primary care physician in Los Angeles County, specializes in expedited cancer workups for uninsured and underinsured patients. Every diagnosis arrives carrying another set of questions about housing, transportation, food insecurity, wages, and survival that rarely appear in medical records or scientific literature. For years, Waltman carried those stories without knowing how to bring them into the academic record. As a full-time clinician without a research lab, grant funding, or publication pipeline, she faced barriers familiar to many working scientists and physicians whose most important observations happen outside traditional research settings. With support from the Life Science Editors Foundation's JEDI program, those experiences became The Margins Matter, a narrative medicine essay published in JAMA that argues the social realities surrounding cancer care are not background details. They are part of the disease itself. Bogler traces how editorial mentorship transformed lived clinical experience into published scholarship while asking a larger question about who gets to shape the scientific record. The conversation examines cancer care, Medicaid, health-related social needs, medical publishing, and the structural incentives that determine which stories become evidence and which disappear from view.The result is a conversation about documentation, visibility, and why the margins of medicine often determine who survives long enough to benefit from its advances.RELATED LINKSDr. Belinda Waltman⁠The Margins Matter | JAMA⁠The Margins Matter | PubMed⁠Life Science Editors Foundation⁠FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What would it take for Texas to become the national leader in health, wellness, and regenerative medicine? On this episode of Texas Talks, host Brad Swail sits down with Jack Collier, co-founder and CEO of Optimized Health and Performance, a nationwide telehealth clinic based in the Austin area. Collier explains how his own experience with hormone testing led him into the health and wellness industry and why he believes patients need more information and control over their healthcare decisions. The conversation covers: Preventive health, hormone optimization, and regenerative medicine Healthcare costs and the role of insurance Peptides and the growing online gray market How Texas could encourage research while protecting consumers The Make Texas Healthy Again movement and health education Why Austin has become a hub for health and wellness innovation Collier argues that Texas has an opportunity to become a national center for emerging healthcare research and innovation while improving health education and giving patients greater choice in how they manage their health. 00:00 — Introduction & Jack Collier 02:09 — Hormone Optimization & Jack's Health Journey 05:09 — The Future of Health & Regenerative Medicine in Texas 09:17 — Prevention, Nutrition & the Current Healthcare Model 16:03 — Healthcare Costs, Insurance & Patient Choice 20:17 — The Long-Term Value of Preventive Health 23:27 — What Texas Can Do Through Public Policy 24:53 — Peptides, Safety & the Online Gray Market 28:53 — Peptide Therapies & Medical Innovation 31:04 — Regulation, Research & the Future of Healthcare 32:40 — Make Texas Healthy Again & Health Education 36:17 — Austin's Health & Wellness Boom Watch Full-Length Interviews: https://www.youtube.com/@TexasTalks Follow us on social mediaX: @Texas_DispatchInstagram: thetexasdispatchLinkedIn: The Texas DispatchTikTok: texas_talks_podcast Find more at The Texas DispatchYour source for state news, policy, and investigative journalism.https://thetexasdispatch.com

In this episode of the B2B Insights Podcast, Beata Miklosz and Niklas Heitland from B2B International speak with Dr Christine Wübben, Postdoctoral Researcher at the University Hospital Bonn, and Sandra Lewash, PhD Researcher at the University Hospital Bonn, about the role market research can play in transforming scientific discoveries into commercially viable healthcare innovations. The discussion focuses on COLDEX, an innovative antiviral nasal spray project developed within the ImmunoSensation Cluster of Excellence. Having demonstrated the scientific feasibility of their technology, the team partnered with B2B International to better understand market needs, validate key assumptions and identify the most promising routes to commercialization. Through a program of market research involving healthcare professionals, patients and other stakeholders, the team gained valuable insights into target audiences, market opportunities, adoption barriers and strategic priorities for future development. Hear Beata, Niklas, Christine and Sandra discuss how market research helped shape the project's direction, reduce risk and strengthen confidence in key innovation decisions. Key discussion points: How COLDEX evolved from fundamental immunology research into a real-world healthcare innovation Why scientific evidence alone is not enough for successful market entry The importance of validating assumptions before making major development and investment decisions How market research helps innovators understand user needs, commercial potential and regulatory considerations Lessons learned from engaging healthcare professionals, patients and other key stakeholders Why prevention-focused innovations can present unique market adoption challenges The value of introducing market research earlier in the innovation process Advice for researchers and innovators looking to bridge the gap between scientific discovery and commercial success

In 1986, 23 survivors, physicians, nurses, attorneys, and community organizers gathered in Albuquerque, New Mexico, for a weekend that would permanently change the language and politics of cancer. Working late into the night, they debated not only strategy, but identity, ultimately declaring that from the moment of diagnosis, every person with cancer is a survivor.This episode traces the social and political forces that gave birth to the modern cancer survivorship movement. As advances in early detection and treatment allowed more people to live beyond cancer, survivors discovered that finishing treatment did not mean returning to normal life. Many faced employment discrimination, loss of insurance, social stigma, infertility, chronic health complications, and a healthcare system that viewed survival as the end of care rather than the beginning of a new chapter.Against the backdrop of the civil rights, disability rights, and community health movements of the 1960s and 1970s, physicians, activists, and survivors challenged medicine's paternalistic culture and demanded a greater voice in decisions affecting their lives. Central to this story are physician and survivor Dr. Fitzhugh Mullan, whose landmark 1985 essay, Seasons of Survival, redefined survivorship as a lifelong continuum, and community organizer Katherine Logan, whose determination united dozens of grassroots organizations into what became the National Coalition for Cancer Survivorship.The coalition's founding established principles that continue to shape oncology today. Survivors were no longer defined solely by disease or treatment outcomes. Their experiences became evidence. Their voices became essential to clinical research, healthcare policy, and patient advocacy. By redefining survivorship as an ongoing experience rather than a destination, the movement challenged medicine to recognize the lasting physical, emotional, financial, and social consequences of cancer.The ideas forged during that weekend in Albuquerque became the foundation of modern cancer survivorship. Nearly 40 years later, the coalition's defining principle, that survivorship begins at diagnosis, continues to influence cancer care, research, policy, and the way millions of people understand life after cancer.RELATED LINKSNational Coalition for Cancer Survivorship⁠National Cancer Institute Office of Cancer Survivorship⁠The New England Journal of Medicine⁠Americans with Disabilities Act (ADA.gov)⁠Library of Congress | Civil Rights History Project⁠White Coat, Clenched Fist by Fitzhugh Mullan⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if the biggest threat to your healthcare organization isn't competition or reimbursement rates — it's the moment one of your team members decided that the policy was more important than the person in front of them? In this episode, Jamie sits down with Matt Staub, CEO of Your Health, to explore the timeless "Give 'Em the Pickle" philosophy — born in a burger joint, but almost perfectly designed for healthcare. Matt and Jamie unpack the four pillars of the pickle framework — service, attitude, consistency, and teamwork — and trace each one directly into the reality of patient care, care team dynamics, and organizational culture. Video LinkGive Em The Pickle Youtube Video   What you'll hear in this episode: Why charging a loyal customer 75 cents for extra pickles is the same mistake healthcare makes every day — and how the Ritz Carlton's $2,500 employee empowerment policy points to a better way How attitude isn't just a soft skill — it's the infrastructure of every patient interaction, including the ones where you're already having a bad day Why mistakes in healthcare aren't failures — they're invitations, and the patients who complained and felt heard often become your fiercest advocates What real consistency looks like in care delivery: not doing the same thing robotically, but doing ordinary things extraordinarily well, every single time How teamwork in healthcare means every person in the organization — from the CEO to the community health worker — has a role in whether the patient feels seen and served This episode will challenge you to look at service not as a department or a satisfaction score, but as the very soul of what your organization stands for. Give 'em the pickle.

What can healthcare innovators learn from an Olympian?In the opening keynote of the 5th Annual Medical Innovation Olympics #MIO2026 at Rockefeller Center in NYC, two-time Olympian swimmer and NHS UK Advisor Chris Cook shares lessons from elite performance and why they matter for leaders transforming healthcare.From missing a major competition by four-hundredths of a second to becoming a champion, Chris explores resilience, accountability, consistency, courage, teamwork, and incremental improvement - connecting world-class performance to turning ambitious healthcare ideas into measurable patient impact.The conversation concludes with a Q&A on failure, motivation, finding your “North Star,” and why the real gold is not the medal, but who you become in pursuit of something bigger than yourself.CHAPTERS00:00 - The Mindset of People Who Change IndustriesTransformative leaders stay uncomfortable longer than everyone else.00:25 - Welcome to the 5th Annual Medical Innovation OlympicsTim Mikhelashvili opens MIO 2026 with its mission: lasting impact on healthcare, society, and patients.01:44 — Introducing Two-Time Olympian Chris CookChris describes MIO as fundamentally different from a traditional conference: “a competition with purpose.”03:26 — What Olympic Performance Can Teach Healthcare InnovatorsChris' Olympic journey, elite performance lessons, and innovators' larger responsibility.03:51 — The Work Nobody Sees Behind High Performance4:30 a.m. starts, sacrifice, injury, doubt, repetition, and discipline reveal how excellence is built through consistent small decisions.05:19 — Losing by 0.04 Seconds—and the Power of “Yet”After missing a major competition by four-hundredths of a second, Chris hears: you're not good enough yet. Four years later, everything changes.06:30 — From Setback to ChampionChris returns to win two gold medals and a silver—and explains how competitors think and respond differently.07:05 — Innovators See Possibility Before There Is ProofOlympians and innovators pursue possibility while others demand proof—and stay uncomfortable long enough to create change.07:42 — Measurement, Accountability & Healthcare ImpactMeasurement creates clarity. AI, data science, and precision medicine are powerful, but transformation also requires leadership and accountability.09:21 — When Innovation Becomes HumanAccess, quality, and continuity of care are not abstract metrics—they affect patients, families, treatment, and time.09:46 — Three Lessons from an OlympianPressure is a privilege. Consistency beats intensity. Great teams outperform great individuals.10:57 — Courage, Competition & Stepping Into the ArenaInnovation requires vulnerability, evaluation, courage, and a willingness to participate rather than stay comfortable.11:36 — Tiny Improvements Can Change Lives at ScaleBetter workflows, faster diagnoses, improved pathways, and breakthrough ideas compound into human impact.12:41 — Q&A: The Healthcare Champions Nobody SeesUnrecognized professionals across safety, pharmacovigilance, product quality.14:25 — “The Real Gold Is the Person You Become”The greatest reward is not the medal - it is who you become while pursuing something bigger than yourself.15:57 — What Do You Do When Nothing Is Working?Q&A: How do you keep moving when experiments fail, progress stalls, and motivation disappears?16:26 — Experiments Don't Fail - They Produce ResultsChris reframes failure: what matters is what you learn from results and what you do next.16:56 — Inspiration, Motivation & Finding Your North StarChris distinguishes enduring inspiration from motivation, which naturally rises and falls.18:24 — Look Back to See How Far You've ComeFocusing only on the gap ahead can demotivate us. Confidence also comes from recognizing how far we have traveled.19:38 — Transformative Power of SportFormer IOC President Thomas Bach closes by reflecting on sport as a force for good and a tool for improving lives.

In 1971, President Richard Nixon signed the National Cancer Act, transforming cancer research with an unprecedented federal investment and launching what became known as the War on Cancer. The legislation did not emerge from scientific discovery alone. It was the culmination of decades of relentless advocacy by researchers, philanthropists, journalists, and patients who believed cancer demanded the same national commitment that had put astronauts on the Moon.This episode traces the origins of the cancer survivorship movement by returning to a time when cancer was rarely discussed in public, many physicians withheld diagnoses from their patients, and surgery offered few lasting cures. It follows the pioneering work of pathologist Dr. Sidney Farber, whose early chemotherapy research challenged conventional thinking, and Mary Lasker, whose political strategy, fundraising, and public campaigns helped transform cancer from a private tragedy into a national public health priority. Together, they built the coalition that reshaped federal support for oncology research and forever changed the relationship between science, government, and the American public.The story then turns to journalist and breast cancer survivor Rose Kushner, whose refusal to accept the standard one-step radical mastectomy challenged nearly a century of surgical dogma. Working alongside surgeon Dr. Bernard Fisher, Kushner helped bring evidence-based medicine to breast cancer treatment through randomized clinical trials that demonstrated less invasive surgery could achieve equivalent outcomes. Their efforts changed clinical practice, strengthened informed consent, and helped establish the principle that patients should participate in decisions about their own care.The breakthroughs explored in this episode extended far beyond new treatments. They redefined the role of patients in medicine, accelerated clinical research, and laid the foundation for modern cancer survivorship. The movement that followed would not simply help more people live longer. It would change what surviving cancer meant.RELATED LINKSNational Cancer Institute⁠National Cancer Act of 1971⁠American Cancer Society⁠Dana-Farber Cancer Institute⁠National Library of Medicine⁠The New England Journal of Medicine⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Please send any questions to podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us Fan MailMedicaid and Medicare used to pay first and chase fraud later. That model is changing fast, and the providers who haven't adapted are about to feel it.In this clip from our episode “AI and The Future Of Behavioral Health”, host John Driscoll and Alon Joffe, Co-Founder and CEO of Eleos Health, break down why the shift to audit-first payment in Medicaid and Medicare is an existential threat for behavioral health organizations already operating on razor-thin margins.Listen to the full episode here

Long before cancer survivors organized into a movement, Hollywood had already shaped how Americans understood the disease. Films rarely used the word “cancer,” physicians often withheld diagnoses from patients, and the people who survived were almost nowhere to be found on screen.Recorded before The Cancer Mavericks: A History of Survivorship became a documentary series, this bonus conversation explores where the project first began. Matthew Zachary sits down with his mother, Roz Greenzweig, a retired educator and lifelong film enthusiast whose memories of classic cinema became an unexpected lens for understanding how cancer was portrayed throughout the twentieth century.Together, they revisit landmark films including Dark Victory, Love Story, and other iconic portrayals that reflected an era when cancer was treated as unspeakable, inevitable, and almost always fatal. Their conversation contrasts those carefully constructed Hollywood narratives with the lived reality of a family confronting a brain cancer diagnosis in 1995, revealing how popular culture both reflected and reinforced the fears surrounding the disease.The discussion also foreshadows many of the themes explored throughout the documentary series: the evolution of patient advocacy, the emergence of cancer survivorship, the role of caregivers, and the power of storytelling to influence public understanding. Before policy changed, before advocacy organizations grew into national movements, conversations like these were already challenging long-held assumptions about what cancer looked like and who had the right to tell its story.Consider this the prologue to The Cancer Mavericks. Before the movement found its history, it began with a family trying to make sense of the stories they had inherited.RELATED LINKSAmerican Cancer Society⁠National Cancer Institute⁠American Film Institute⁠ER (NBC)⁠50/50 (Official)⁠Chasing Life (ABC Family Archive)⁠FEEDBACKLike this episode? Rate and review The Cancer Mavericks: A History of Survivorship on your favorite podcast platform. For more information, visit CancerMavericks.com. Questions? Email podcasts@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us Fan MailMore than 160 million Americans live in areas with a shortage of mental health providers. The clinicians who do show up are spending hours on documentation, compliance, and eligibility work that has nothing to do with patient care.Alon Joffe, Co-Founder and CEO of Eleos Health, joins host John Driscoll to discuss how AI is reducing administrative burden for behavioral health clinicians and why workflow efficiency is becoming critical for community health centers facing Medicaid funding challenges.

What does it take to protect chiropractic around the world?In this episode of TechTalk, Dr. Jay Greenstein and Brad Cost sit down with Bharon Hoag, founder of One Chiropractic, to discuss the legal, political, and regulatory battles shaping the future of chiropractic care across the globe.Bharon shares how his organization has successfully defended chiropractors in more than 800 cases, why countries like Canada, Australia, Spain, and Guam are facing major regulatory challenges, and how strategic advocacy is helping preserve patient access to chiropractic care.The conversation also dives into one of the profession's biggest opportunities in decades: the MAHA movement, Medicare modernization, military integration, chiropractic research funding, reimbursement reform, and what these changes could mean for practitioners and patients alike.Whether you're a chiropractor, healthcare leader, student, or advocate for conservative healthcare, this episode offers an inside look at the policies and people shaping the future of the profession.In this episode:How One Chiropractic has won over 800 advocacy battlesWhy chiropractors are facing new legal challenges worldwideThe future of MAHA and chiropracticMedicare modernization and reimbursement reformChiropractic's role in military healthcareWhy the next two years could redefine the professionTopics: Chiropractic, Healthcare Policy, MAHA, Medicare, Bharon Hoag, One Chiropractic, Chiropractic Advocacy, Healthcare Innovation, TechTalk Podcast, Dr. Jay Greenstein, Brad Cost, Chiropractic Leadership

Artificial intelligence is rapidly becoming part of nearly every conversation in healthcare, but many executives are still asking the same question: What do I actually need to understand to make good business decisions? On this episode of The Dish on Health IT, Brian Dwyer, Business Strategist at Point-of-Care Partners, is joined by Sam Schifman, Principal Engineer for AI at Red Hat and Consultant at Point-of-Care Partners, and Kendra Obrist, Senior Consultant and Payer Interoperability Subject Matter Expert at Point-of-Care Partners, for a practical discussion about how healthcare leaders can evaluate AI opportunities without needing to become technical experts. Together, they explore where AI is delivering measurable value today, why many initiatives struggle to achieve expected outcomes, how to evaluate vendors and risk, what emerging policy and governance trends mean for healthcare organizations, and why strong data quality and interoperability remain essential to AI success. The conversation begins by unpacking what people actually mean when they say they're "using AI." Sam explains the differences between predictive AI, generative AI, conversational AI, and the rapidly emerging world of agentic AI, while Kendra encourages listeners not to get caught up in the terminology. Instead, she emphasizes starting with the business problem that needs to be solved and then determining whether AI is the right tool for the job. Brian then asks where AI is creating meaningful value today. Kendra highlights opportunities across administrative workflows, including documentation, member and provider engagement, claims, prior authorization, and other operational processes where reducing friction can improve efficiency and the user experience. Sam builds on that discussion by encouraging organizations to evaluate AI initiatives based on business outcomes and measurable success metrics rather than technical benchmarks, while recognizing that every AI implementation introduces its own set of risks and tradeoffs. The discussion shifts to why technically impressive AI projects often fail to produce meaningful business results. Kendra explains that organizations can become captivated by polished demonstrations without fully considering governance, data quality, workflow redesign, adoption, and organizational change management. Sam reinforces the importance of understanding AI's inherent uncertainty, establishing appropriate human oversight, and preparing employees for new ways of working as AI becomes integrated into everyday operations. Brian next explores how much AI healthcare executives actually need to understand. Rather than suggesting leaders become AI specialists, Sam encourages executives to develop enough knowledge to ask informed questions and avoid treating AI as an incomprehensible "black box." Kendra complements that advice by encouraging leaders to personally experiment with AI tools so they can better understand both their strengths and limitations before making strategic decisions. As organizations increasingly evaluate AI-enabled products, the panel discusses the questions healthcare leaders should ask prospective vendors. Beyond understanding how an AI solution works, they explore governance, transparency, auditability, accountability, data requirements, quality assurance, and vendor responsibility when AI produces unexpected results. Sam also introduces the concept of AI sovereignty, encouraging organizations to think carefully about long-term dependence on foundational AI models and the flexibility they'll need as technology and regulations continue to evolve. The conversation also examines the rapidly changing policy landscape surrounding AI. Kendra explains how federal agencies are currently taking a sector-specific approach to oversight while states continue introducing their own transparency, bias, and human review requirements. Together, they discuss the operational challenges this evolving patchwork of regulations creates for healthcare organizations operating across multiple states and why adaptability will become increasingly important. Looking ahead, Brian asks what developments deserve executives' attention and which trends may be receiving more attention than they warrant. Sam discusses why organizations should avoid assuming generative AI is always the right answer, highlighting continued opportunities for predictive AI, machine learning, and even traditional software approaches when they better fit the problem. Kendra shares why agentic AI and coordinated teams of AI agents may fundamentally reshape how work is performed across healthcare organizations. The episode concludes with each guest sharing one final takeaway for healthcare leaders. Sam encourages organizations to begin thinking strategically about AI sovereignty, security, and organizational flexibility as AI becomes increasingly embedded in core business operations. Kendra leaves listeners with a broader perspective, comparing AI's impact on knowledge work to the Industrial Revolution's impact on physical labor, and encourages leaders to embrace the technology thoughtfully rather than waiting until they feel they have all the answers. This episode offers practical guidance for healthcare executives who want to make informed AI decisions, ask better questions of vendors and internal teams, and develop an AI strategy grounded in business value rather than technology for technology's sake. Would you be interested in joining a future AI 101 webinar designed for healthcare executives? Sign up to be invited and tell us what you want to learn. We may not be able to pack everything into one webinar but we can do our best to make it as informative as possible. 

Send us Fan MailA triplet birth in the United States costs roughly $577,000. A twin birth runs about $155,000. For a self-insured employer, that cost hits the bottom line directly.In this clip from our episode “Making Fertility Benefits An Employer Priority”, host David E. Williams and David Stern, CEO of Kindbody, break down how Kindbody puts skin in the game with employers through contractual guarantees on multiple birth rates, miscarriage rates, and time to care.Listen to the full episode here

Send us a MessageIn this episode of Culture Change RX, Sue welcomes Mark Allen, founder of Rural Health Engine, for a conversation about innovation, technology, and the future of rural healthcare.Mark shares how his journey—from growing up in rural Missouri, to serving in the U.S. Coast Guard, to helping innovative technology companies—ultimately led him to create Rural Health Engine, a nonprofit dedicated to connecting rural hospitals with practical, affordable innovations.Rather than selling products, Mark sees his role as helping rural healthcare leaders discover what's already available and determine which innovations truly fit their organization's needs.The conversation explores why innovation isn't just about adopting artificial intelligence or new software. It's about asking better questions, thinking differently, and recognizing that doing nothing may be the greatest risk of all.To learn more about Rural Health Engine, complete the Innovation Readiness Assessment, or connect with Mark Allen:Website: Rural Health EngineEmail: allen@ruralhealthengine.org[FREE Webinar] A 5-Step Approach to Achieving Nursing Excellence in Rural Hospitals:  Aug 11 at Noon ETMany rural hospitals need a proven approach for creating and sustaining nursing excellence. Join Capstone for a special 1-hour webinar where we will overview our proven 5-step approach for achieving nursing care improvements that take hold and last.Register here: https://capstoneleadership-net.zoom.us/meeting/register/gCRrqIc2QeK7mj-1gzIJsgHi! I'm Sue Tetzlaff. I'm a culture and execution strategist for small and rural healthcare organizations - helping them to be the provider and employer-of-choice so they can keep care local and margins strong.For decades, I've worked with healthcare organizations to navigate the people-side of healthcare, the part that can make or break your results. What I've learned is this: culture is not a soft thing. It's the hardest thing, and it determines everything.When you're ready to take your culture to the next level, here are three ways I can help you:1. Listen to the Culture Change RX PodcastEvery week, I share conversations with leaders who are transforming healthcare workplaces and strategies for keeping teams engaged, patients loyal, and margins healthy. 2. Subscribe to our Email NewsletterGet practical tips, frameworks, and leadership tools delivered right to your inbox—plus exclusive content you won't find on the podcast.

Rebecca Bloom is a former employee benefits and executive compensation attorney who spent more than 25 years helping women navigate cancer, work, insurance, disability coverage, and financial survival. She is the founder and author of When Women Get Sick, a book built from decades inside the legal, workplace, and patient advocacy systems most people only discover after diagnosis.Bloom started in Big Law at Simpson Thacher handling employee benefits and compensation work she originally chose to pay off student loans. Then her mother was diagnosed with breast cancer. Suddenly the language she used in corporate law offices became the language of survival at home. Explanation of benefits forms. Coverage disputes. Second opinions. Disability protections. Medical leave. Bills no one could explain.That collision changed the direction of her life.In this episode, Bloom explains how serious illness quietly turns patients into unpaid administrators managing paperwork, logistics, financial risk, and emotional labor while trying to survive treatment. She breaks down how employer based health insurance shapes nearly every aspect of cancer care in America and why women often carry the invisible burden of protecting everyone else from discomfort while they themselves fall apart.The conversation digs into workplace power, the illusion of the healthcare “safety net,” caregiver exhaustion, and the class divide hiding underneath patient empowerment culture. Bloom explains why educated, insured women with resources still struggle to navigate healthcare bureaucracy and what happens to patients without those advantages.This episode explores cancer care, health insurance, employee benefits, patient advocacy, workplace protections, caregiving, and the structural incentives that force sick people to become project managers of their own survival.RELATED LINKSRebecca BloomWhen Women Get SickBay Area Cancer ConnectionsSimpson Thacher & BartlettFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Abramson advocates for public manufacturing of drugs, independent data review, and better sources like FDA labels and “Worst Pills, Best Pills.” #SystemicReform #PublicHealth #EvidenceFirst

Hey there Voices of the Bench community, this is Trish Jones with Ivoclar. If you've been curious about fast-firing zirconia to improve efficiency but aren't convinced it can deliver predictable, high-quality results, I'd encourage you to connect with us. Our new IPS Emax Zirconia offers multiple fast-fire protocols designed to help save you valuable production time while maintaining consistent results. Time is money in every lab. Don't wait. Reach out to your local Ivoclar rep today and discover how IPS Emax Zirconia can help streamline your workflow. As full-arch dentistry continues to grow, so do the demands on today's dental laboratories. That's why Knight Dental recently launched SimplyARCH Studio, a dedicated production environment built exclusively for full-arch restorations. To support this specialized workflow, Knight invested in an XTCERA milling system and carefully evaluated multiple CAM software solutions before choosing hyperDENT. The decision came down to exceptional milling quality, minimal hand finishing, and impressive production efficiency. But what truly set hyperDENT apart was the implementation process. From the very beginning, the team provided more than software training—they shared the knowledge and experience needed to build an optimized workflow for complex full-arch cases. With proven expertise in advanced milling strategies and laboratory production, hyperDENT helped ensure SimplyARCH Studio was designed for long-term success from day one.Matt Everatt joins Elvis and Barb for a fascinating conversation that takes a deep dive into his journey through the dental laboratory industry and the story behind his book, The Invisible Profession. From discovering dental technology at 16 and specializing in maxillofacial prosthetics and orthodontics to working in hospitals, developing early sleep-apnea appliances, and nearly leaving the profession altogether, Matt's career has taken some seriously interesting turns. Eventually, he helped co-found S4S, building a successful business around sleep-apnea appliances, occlusal splints, orthodontics, and more before eventually stepping away from ownership. Matt Everatt joins Elvis and Barb for a fascinating conversation that takes a deep dive into his journey through the dental laboratory industry and the story behind his book, The Invisible Profession. From discovering dental technology at 16 and specializing in maxillofacial prosthetics and orthodontics to working in hospitals, developing early sleep-apnea appliances, and nearly leaving the profession altogether, Matt's career has taken some seriously interesting turns. Eventually, he helped co-found S4S, building a successful business around sleep-apnea appliances, occlusal splints, orthodontics, and more before eventually stepping away from ownership. But this conversation goes far beyond Matt's career. His book, The Invisible Profession, explores how the dental laboratory industry arrived at a place where technicians and laboratories are often undervalued, pushed into price competition, and expected to simply keep their heads down and produce. Matt shares his thoughts on the "million little things" that shaped the industry, the danger of becoming a "busy fool," and why laboratories need to stop competing solely on price and start becoming known for the value, expertise, and partnership they bring to the dental team. Elvis, Barb, and Matt also talk about the changing landscape of digital dentistry, AI, 3D printing, speed, service, and why the labs that embrace change and remain agile will be the ones positioned for the future. It's an honest, thought-provoking, and ultimately optimistic conversation about where the dental laboratory profession has been, where it is today, and where it can go next.Special Guest: Matt Everatt.

Send us Fan MailFertility benefits have gone from a Silicon Valley recruiting perk to a boardroom priority in under a decade. Employers are no longer just offering access. They are demanding measurable outcomes, transparent costs, and clinical accountability.David Stern, CEO of Kindbody, joins host David E. Williams to discuss why the vertically integrated model of combining a fertility benefit manager with owned clinics is producing better outcomes for employers and patients alike, and what it means that a company serving Walmart employees in rural Arkansas is now one of the most important access stories in American reproductive medicine.

The global healthcare landscape is being redefined, creating new opportunities for healthcare leaders to improve outcomes and expand access. In this episode we sat down with Eugene Sayan, Founder and CEO of Softheon, to explore how AI is empowering consumers, and driving a new era of innovation across the industry. With more than three decades of experience in healthcare technology, Eugene shares his perspective on the forces transforming healthcare delivery, from patient engagement and personalized care to interoperability, affordability, and the growing role of AI agents. He discusses the shift to a proactive approach that leverages data, automation, and intelligent systems to improve outcomes while reducing costs. The conversation also examines the future of healthcare organizations, the importance of responsible AI adoption, and the opportunities healthcare leaders have to build more connected, sustainable, and patient-focused experiences.  Chapter Timestamps: 00:00 Preview Clip 00:57 Introduction 01:33 Eugene's Background and Journey to Softheon 04:17 Consumer Engagement, Analytics, and Healthcare Innovation 06:29 AI, Personalization, and the Future of Care 09:13 AI Agents, Automation, and the Importance of Human Oversight 12:45 Consumer Empowerment and Rising Healthcare Costs 17:33 Provider Sponsored Health Plans and Value Based Care 18:19 Enabling Healthcare at Home Through Technology 23:18 The Power of Digital Engagement and Automation 24:25 Global Healthcare Innovation and Expanding Access 29:15 Ethical AI, Governance, and the Path to AGI 33:21 Interoperability, Data Portability, and What's Next If you're a healthcare executive, provider, payer leader, or healthcare innovator, this conversation offers valuable insights into the opportunities and challenges shaping the future of care. Connect with Eugene on LinkedIn at https://www.linkedin.com/in/eugenesayan Find Eugene's work at https://softheon.com Subscribe and stay at the forefront of the digital healthcare revolution. Find out why we're the fastest growing digital health channel on YouTube!  The Digital Healthcare Experience is a hub to connect healthcare leaders and tech enthusiasts. Powered by Taylor Healthcare, this podcast is your gateway to the latest trends and breakthroughs in digital health. Learn more about The Digital Healthcare Experience here. Taylor Healthcare empowers healthcare organizations to thrive in the digital world. Our technology streamlines critical workflows such as procedural & surgical informed consent with patented mobile signature capture, ransomware downtime mitigation, patient engagement and more. For more information about Taylor Healthcare, please visit imedhealth.com   The Digital Healthcare Experience Podcast: Powered by Taylor Healthcare Produced by Naomi Schwimmer  Hosted by Chris Civitarese Edited by Eli Banks Music by Nicholas Bach  

Send us Fan MailWhat if the companies profiting most from healthcare's data problem are also the ones best positioned to explain why it needs to be solved?In this clip from our episode “Health Data Is Broken And We're Paying For It”, host John Driscoll and Michael Meucci, CEO of Arcadia, break down why the free market has proven it cannot fix healthcare data fragmentation on its own, and what becomes possible when health systems stop spending so much money just moving data around.Listen to the full episode here

Vasanta Pundarika built her career inside healthcare investment banking before launching Lotuspring, an advisory firm focused on women's health and behavioral health. She spent nearly 20 years advising healthcare systems, treatment providers, and growth stage companies on mergers, financing, and operational strategy while watching the industry repeatedly misunderstand the people it claimed to serve.The conversation starts unexpectedly with anthropology, bread, and language. Vasanta explains how she spent years changing the pronunciation of her own name to make other people comfortable before eventually reclaiming it. That thread opens into a much larger discussion about adaptation, identity, and what institutions quietly train people to tolerate.From there, the discussion moves into behavioral health, women delaying care, and the invisible labor that healthcare business models routinely ignore. During COVID, Vasanta noticed men's behavioral health units refilled faster than women's units. The reason had nothing to do with demand. Women were still home managing caregiving responsibilities, children, aging parents, and households while their own mental health collapsed in the background.The episode examines what happens when healthcare companies become “snazzy big brands” before building real clinical substance underneath. Vasanta describes the tension between mission and margin inside healthcare startups, private equity backed care models, and behavioral health expansion. The conversation pushes on who benefits when healthcare scales aggressively, who absorbs the operational pressure, and how patient trust erodes long before executives notice it on a dashboard.They also discuss patient advocacy culture, anthropology as systems analysis, healthcare capitalism, prior authorization, investor language, and why some clinically excellent companies never survive long enough to scale.RELATED LINKSVasanta PundarikaLotuspringWomen's Health HorizonsSakhi for South Asian SurvivorsNACDPrinceton University Anthropology DepartmentFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us Fan MailAmerican healthcare spends an estimated $110 per member per month just to administer itself, before a single service is ever delivered. Most of that cost exists because health data still cannot move freely between the systems that need it.Michael Meucci, CEO of Arcadia, joins host John Driscoll to discuss why two decades of interoperability policy have failed to solve the data fragmentation problem facing health systems and payers, and why liberating that data and redirecting the administrative spend it currently requires could be the single biggest lever available for improving both the cost and quality of American healthcare.

In this episode of TechTalk, Dr. Jay Greenstein and Brad Cost sit down with Dr. Cory Frogley - entrepreneur, chiropractor, healthcare technology innovator, and founder of BlueIQ, Prime Practice, and Driven OS - to discuss how artificial intelligence, leadership, data analytics, and business systems are reshaping modern chiropractic practices.Dr. Frogley shares his journey from building Utah's largest holistic healthcare center to becoming one of the industry's leading voices on AI-powered practice management. Together, they explore why chiropractors must embrace technology, how data can improve patient outcomes and insurance reimbursement, what separates successful practice owners from overwhelmed providers, and why the future belongs to leaders who combine clinical excellence with innovation.Whether you're a chiropractor, healthcare entrepreneur, clinic owner, or healthcare technology enthusiast, this episode delivers actionable strategies for building a profitable, patient-centered practice while preparing for the next generation of healthcare.To connect with Dr. Frogley, you can find him on Facebook, TikTok, LinkedIn, and Instagram @/Dr. CoryFrogley or visit his websites at BlueIQ.com, at PrimePractice.com, or at DrivenDocs.com.Topics Covered:Artificial Intelligence in chiropracticBuilding a high-performance practice cultureLeadership vs. being the bottleneckHealthcare data & patient outcomesInsurance reimbursement challengesPractice growth strategiesAI-powered documentationHealthcare innovationThe future of chiropractic technology

Send us Fan MailWhen a teenager expresses suicidal thoughts to an AI chatbot, what happens next?In this clip from our episode “Who Sets the Rules for AI in Medicine?”, hosts David E. Williams and John Driscoll and Dr. John Whyte, CEO of the American Medical Association, break down why minors need stronger protections from AI chatbots than adults do, and why the line between a wellness app and a medical device matters more than the industry wants to admit.Listen to the full episode here

Brad Power spent years advising major corporations on systems design, process engineering, and decision making before lymphoma shoved him into the patient side of American healthcare. Instead of accepting the experience at face value, he started reverse engineering the machinery around cancer itself. Brad is the founder of Cancer Patient Lab and Open Cancer AI, two projects built around a blunt reality most patients discover too late: the healthcare system rewards people who know how to navigate it. Everyone else risks getting steamrolled by information asymmetry, insurance barriers, administrative friction, and institutional incentives designed around efficiency instead of human survival.The conversation starts with Harvard Business Review and Tumblr blogs before moving directly into the darker architecture underneath modern cancer care. Power explains how hospitals optimize for throughput, how insurance companies reward operational consistency over personalized medicine, and why many patients quietly end up needing a crash course in oncology, reimbursement policy, and behavioral psychology while fighting for their lives.The discussion digs into CAR-T therapy, functional testing, AI assisted decision support, and the growing collision between personalized medicine and standardized care pathways. Power argues that engaged patients often get better outcomes because they learn how to push for off guideline treatments, contest denials, and ask smarter questions. The counterpoint lands hard: patients should never have needed to become experts in the first place.The episode also explores the cultural consequences of AI entering cancer care. OpenAI advertising, data privacy, trust erosion, pharmaceutical influence, and “agentic AI” all collide inside a healthcare economy already drowning in distrust. Power sees artificial intelligence as a force multiplier for patient literacy and access. The larger system still decides who gets approved, who gets delayed, and who gets left behind.By the end, the conversation lands exactly where modern healthcare keeps forcing people to land: survival increasingly depends on learning how the machine works before the machine works on you.RELATED LINKSBrad PowerCancer Patient LabOpen Cancer AIHarvard Business ReviewResearch to the PeopleCAR T Cell TherapyFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The American healthcare system is built around a simple idea: get sick, get treated. But what if the problem isn't how we treat illness — it's that we've never seriously tried to prevent it? In this first installment of a two-part conversation, Jamie sits down with Brody Wall, Division President of Operations at Your Health, to trace the arc from a broken, reactive healthcare system to one where data tells you what's coming before the patient even knows something is wrong. Brody's path to healthcare wasn't through a textbook — it was through a father who was a Methodist minister and a mother who spent her career caring for underprivileged children. The mission was always there. The data just became the most honest way to fulfill it. In Part 1, Jamie and Brody cover: Why fee-for-service healthcare financially rewards volume of sick visits — not health — and how that one incentive structure explains why 17-20% of America's GDP goes to healthcare costs with outcomes that still lag behind other developed nations What Your Health was flying blind on before it committed to building a real data infrastructure — and what gut-feeling decisions look like when data finally proves them wrong How social determinants of health (Z codes) and behavioral health conditions (F codes) reveal which patients are actually at the highest risk of hospitalization The finding that changed everything: patients with four or more behavioral health conditions were ten times more likely to have multiple ER visits — and the clinical response that followed This isn't just a conversation about numbers. It's about what happens when an organization decides that preventing the crisis matters more than reacting to it. Part 2 drops next week. www.YourHealth.Org

Send us Fan MailEighty-one percent of physicians are already using AI in practice, more than double the rate from just three years ago. The tools are moving faster than the rules, and nobody has agreed on who gets to write them.Dr. John Whyte, CEO of the American Medical Association, joins hosts David E. Williams and John Driscoll to discuss why the medical community needs to lead the conversation on AI guardrails rather than wait for Washington to catch up, and why the most urgent regulatory question right now involves AI chatbots in mental health, where one in six American adults are already using them with no meaningful oversight in place.

By the time the paper hit version 71, Dr. Nirosha Murugan had already done the hard part. The data were real. The experiment had worked. A team of researchers had used a wearable bioreactor to trigger limb regeneration in frogs, a result with obvious implications for regenerative medicine. But the science still wasn't getting over the line. The problem wasn't the work. It was the translation.On this episode of Standard Deviation, host Oliver Bogler talks with Dr. Nirosha Murugan, a biophysicist and Tier II Canada Research Chair in Tissue Biophysics at Wilfrid Laurier University, about what happens when a scientist working at the edges of quantum biology, bioelectricity, and tissue regeneration runs headfirst into the unwritten rules of academic publishing. Murugan's research asks biologists to think beyond molecules and chemistry alone, and to consider the physical signals, electromagnetic fields, and invisible forces that shape development and healing. It is ambitious science. It is also exactly the kind of work that can make gatekeepers nervous.Bogler follows Murugan through the less glamorous part of discovery: the hidden curriculum of getting a paper published, securing scientific credibility, and learning that data do not simply “speak for themselves.” Murugan describes how jargon buried the pitch of her own work, how a lack of editorial support left her at a disadvantage, and how the JEDI program at the Life Science Editors Foundation paired her with a former journal editor who taught her how to structure a manuscript, write a cover letter, and survive peer review.The result was publication in Science Advances, but the larger story is about power. Who gets taught the rules of biomedical research. Who has access to grant writers, editors, and institutional polish. Who is left to brute-force their way through the maze. And how one scientist, having finally found the map, now makes sure her own trainees do not have to learn it the hard way.RELATED LINKSDr. Nirosha Murugan⁠Wilfrid Laurier University⁠Life Science Editors Foundation⁠JEDI Program⁠Science Advances paper on limb regeneration⁠FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us Fan MailThere are very few cures for cancers that have already spread. So what does a good outcome actually look like?In this clip from our episode “How Targeted Radiotherapy Is Changing Cancer Care”, host David E. Williams and John Babich, Founder, President, and Chief Scientific Officer of Ratio Therapeutics, break down what extending life with quality really means in cancer care, and why giving someone eight more months where they can still live their life is the philosophy driving the work at Ratio Therapeutics.Listen to the full episode here

Dr. Jess Peatross trained in conventional medicine and worked as a hospitalist before she started questioning why so many chronically ill patients kept getting worse inside the healthcare system she trusted. Her perspective carries weight because she spent years following every protocol exactly as taught before walking away from hospital medicine entirely.Raised in Huntington, West Virginia during the opioid crisis, she entered medicine believing the system existed to heal people. Instead, she found hospitals driven by billing codes, liability management, and pharmaceutical dependence while patients with chronic illness, autoimmune disease, mold exposure, and chronic pain cycled endlessly through appointments and prescriptions.Dr. Peatross explains what pushed her toward functional medicine, cannabis therapy, and prevention focused care after watching patients improve only after leaving conventional treatment pipelines behind. The conversation tackles physician burnout, chronic illness stigma, healthcare incentives, and the growing collapse of trust between patients and institutions.The discussion also moves into supplements, environmental toxins, ultra processed food, and the uncomfortable economics behind keeping people permanently sick but continuously billable. Dr. Peatross describes the professional backlash that comes with challenging medical orthodoxy while Matthew connects her experience to the broader erosion of public trust across American healthcare.Together they unpack what happens when patients stop believing the system can help them and start searching elsewhere for answers.RELATED LINKSDr. Jess PeatrossInstagramMarshall UniversityBrave New WeedFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.